NM_000136.3:c.*1871G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000136.3(FANCC):​c.*1871G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.387 in 232,466 control chromosomes in the GnomAD database, including 18,478 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.38 ( 11349 hom., cov: 32)
Exomes 𝑓: 0.41 ( 7129 hom. )

Consequence

FANCC
NM_000136.3 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.282

Publications

16 publications found
Variant links:
Genes affected
FANCC (HGNC:3584): (FA complementation group C) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group C. [provided by RefSeq, Jul 2008]
AOPEP (HGNC:1361): (aminopeptidase O (putative)) This gene encodes a member of the M1 zinc aminopeptidase family. The encoded protein is a zinc-dependent metallopeptidase that catalyzes the removal of an amino acid from the amino terminus of a protein or peptide. This protein may play a role in the generation of angiotensin IV. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.548 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCCNM_000136.3 linkc.*1871G>A 3_prime_UTR_variant Exon 15 of 15 ENST00000289081.8 NP_000127.2 Q00597A0A024R9N2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCCENST00000289081.8 linkc.*1871G>A 3_prime_UTR_variant Exon 15 of 15 1 NM_000136.3 ENSP00000289081.3 Q00597
FANCCENST00000375305.6 linkc.*1871G>A 3_prime_UTR_variant Exon 15 of 15 1 ENSP00000364454.1 Q00597
FANCCENST00000696260.1 linkn.4363G>A non_coding_transcript_exon_variant Exon 3 of 3
AOPEPENST00000710812.1 linkn.410+19056C>T intron_variant Intron 4 of 4

Frequencies

GnomAD3 genomes
AF:
0.376
AC:
57055
AN:
151922
Hom.:
11343
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.474
Gnomad AMR
AF:
0.473
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.567
Gnomad SAS
AF:
0.455
Gnomad FIN
AF:
0.461
Gnomad MID
AF:
0.351
Gnomad NFE
AF:
0.407
Gnomad OTH
AF:
0.391
GnomAD4 exome
AF:
0.410
AC:
32979
AN:
80426
Hom.:
7129
Cov.:
0
AF XY:
0.406
AC XY:
15095
AN XY:
37210
show subpopulations
African (AFR)
AF:
0.240
AC:
919
AN:
3834
American (AMR)
AF:
0.487
AC:
1194
AN:
2454
Ashkenazi Jewish (ASJ)
AF:
0.306
AC:
1555
AN:
5074
East Asian (EAS)
AF:
0.566
AC:
6389
AN:
11286
South Asian (SAS)
AF:
0.434
AC:
307
AN:
708
European-Finnish (FIN)
AF:
0.543
AC:
50
AN:
92
Middle Eastern (MID)
AF:
0.343
AC:
170
AN:
496
European-Non Finnish (NFE)
AF:
0.399
AC:
19884
AN:
49788
Other (OTH)
AF:
0.375
AC:
2511
AN:
6694
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
980
1960
2940
3920
4900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
108
216
324
432
540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.375
AC:
57067
AN:
152040
Hom.:
11349
Cov.:
32
AF XY:
0.382
AC XY:
28393
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.237
AC:
9818
AN:
41490
American (AMR)
AF:
0.473
AC:
7229
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
1052
AN:
3468
East Asian (EAS)
AF:
0.566
AC:
2907
AN:
5140
South Asian (SAS)
AF:
0.455
AC:
2189
AN:
4816
European-Finnish (FIN)
AF:
0.461
AC:
4878
AN:
10584
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.407
AC:
27626
AN:
67946
Other (OTH)
AF:
0.395
AC:
836
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1770
3541
5311
7082
8852
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.380
Hom.:
4591
Bravo
AF:
0.369
Asia WGS
AF:
0.480
AC:
1666
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Fanconi anemia complementation group C Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.88
DANN
Benign
0.46
PhyloP100
-0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4647558; hg19: chr9-97862118; API